|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 6
2021
Arakawa, Akiko; Kambe, Naotomo; Nishikomori, Ryuta; Tanabe, Akiyo; Ueda, Masamichi; Nishigori, Chikako; Miyachi, Yoshiki und Kanazawa, Nobuo
(2021):
NOD2 Mutation-Associated Case with Blau Syndrome Triggered by BCG Vaccination.
In: Children-Basel, Bd. 8, Nr. 2, 117
Arakawa, Akiko; Reeves, Emma; Vollmer, Sigrid; Arakawa, Yukiyasu; He, Mengwen; Galinski, Adrian; Stöhr, Julia; Dornmair, Klaus; James, Edward und Prinz, Jörg C.
(2021):
ERAP1 Controls the Autoimmune Response against Melanocytes in Psoriasis by Generating the Melanocyte Autoantigen and Regulating Its Amount for HLA-C*06:02 Presentation.
In: Journal of Immunology, Bd. 207, Nr. 9: S. 2235-2244
2020
Uchida, Youhei; Gherardini, Jennifer; Schulte-Mecklenbeck, Andreas; Alam, Majid; Cheret, Jeremy; Rossi, Alfredo; Kanekura, Takuro; Gross, Catharina C.; Arakawa, Akiko; Gilhar, Amos; Bertolini, Marta und Paus, Ralf
(2020):
Pro-inflammatory V delta 1(+)T-cells infiltrates are present in and around the hair bulbs of non-lesional and lesional alopecia areata hair follicles.
In: Journal of Dermatological Science, Bd. 100, Nr. 2: S. 129-138
2019
Arakawa, Akiko; Vollmer, Sigrid; Tietze, Julia; Galinski, Adrian; Heppt, Markus V.; Buerdek, Maja; Berking, Carola und Prinz, Jörg C.
(18. Juni 2019):
Clonality of CD4+ Blood T Cells Predicts Longer Survival With CTLA4 or PD-1 Checkpoint Inhibition in Advanced Melanoma.
In: Frontiers in Immunology, Bd. 10, 1336: S. 1-12
[PDF, 3MB]
2018
Arakawa, Akiko; Vollmer, Sigrid; Besgen, Petra; Galinski, Adrian; Summer, Burkhard; Kawakami, Yoshio; Wollenberg, Andreas; Dornmair, Klaus; Spannagl, Michael; Ruzicka, Thomas; Thomas, Peter und Prinz, Jörg C.
(2018):
Unopposed IL-36 Activity Promotes Clonal CD4(+) T-Cell Responses with IL-17A Production in Generalized Pustular Psoriasis.
In: Journal of Investigative Dermatology, Bd. 138, Nr. 6: S. 1338-1347
2016
Arakawa, Akiko; Ruzicka, Thomas und Prinz, Jörg C.
(2016):
Therapeutic Efficacy of Interleukin 12/Interleukin 23 Blockade in Generalized Pustular Psoriasis Regardless of IL36RN Mutation Status.
In: Jama Dermatology, Bd. 152, Nr. 7: S. 825-828